Journal rankings · indicator year 2001
Choose a field to open its ranking, or a journal to find its row in its subfield’s list.
Subfield ranking · 2001
Immunology journal rankings 2001
59 ranked journals · Subfield in Immunology and Microbiology
Immunology has 59 ranked journals in 2001. The median OJR rose 0.07 on 2000 to 0.78, below the world average of 1.00; Q1 starts at OJR 1.25. The top three are Immunity, The Journal of Experimental Medicine, and Nature Immunology.
Ranks and citation indicators: 2001. Journal access status and listed APC: source snapshot September 23, 2026.
Journals whose main subfield sits in this category and that published at least 30 citable documents (articles, reviews and conference papers) in 1998–2000, the window the 2001 score is computed on.
The OpenJournalRank Indicator (OJR) is a free, publicly available metric of a journal’s field-normalized citation impact, computed from open OpenAlex citation data. It compares citations to a journal’s papers from the previous three years with the world average for papers of the same subfield, year and type, so 1.00 is the world average and values can be compared across fields. It is computed with the NCI3 method.
The middle OJR among ranked journals in this category: half score higher, half lower. 1.00 is the world average for papers of the same subfield, year and type.
The dot is this category, the solid tick is the median of all ranked journals and the dashed line is the world average.
Share of ranked journals in this category that are fully open access, so every paper is free to read. Hybrid journals, which sell subscriptions and open single papers for a fee, are not counted.
Median list price of the article processing charge, in US dollars, among ranked journals in this category that list a price above zero. Journals with a listed APC of $0 and journals with no known price are left out of this median. The At a glance table below gives a second median that includes the $0 prices.
Subfields of Immunology and Microbiology (5)
59 ranked journals
Filters
Rank is the position by OJR within the list on screen; 1 is the highest. | OJR is field-normalized 3-year citation impact: 1.00 is the world average for papers of the same subfield, year and type, so values compare across fields. The badge is the journal’s quartile in this list. | Citations per paper over a two-year window, counted from OpenAlex. It is not field-normalized, so compare it only between journals of the same field. ▲ or ▼ is the change from 2000. This is OpenJournalRank’s own count, not Clarivate’s Journal Impact Factor. | Citable documents (articles, reviews and conference papers) published in 1998–2000, the window the 2001 OJR is computed on. A journal needs at least 30 to be ranked. | Share of the journal’s 1998–2000 papers that are free to read in any open-access form. The green OA tag next to a title marks a fully open-access journal. | List price of the article processing charge in US dollars. “$0 listed” means the listed price is zero; a dash means no price is listed. | The line is the journal’s OJR from 2000 to 2001. | Compare |
|---|---|---|---|---|---|---|---|
1ImmunityCell Press · United States | 6.56Q1 | 19.10 1.91 down from 2000 | 466 | 94% | $10,400 | ||
2The Journal of Experimental MedicineRockefeller University Press · United States | 5.21Q1 | 15.06 0.11 up from 2000 | 1,280 | 98% | — | ||
3Nature ImmunologyNature Portfolio · United States | 4.45Q1 | 10.54no 2000 value | 117 | 11% | $12,690 | — | |
4Annual Review of ImmunologyAnnual Reviews · United States | 3.78Q1 | 48.65 3.88 down from 2000 | 84 | 4% | — | ||
5Immunology TodayElsevier BV · United Kingdom | 2.93Q1 | 7.76 0.87 down from 2000 | 513 | — | — | ||
6Critical Reviews in ImmunologyBegell House · United States | 2.38Q1 | 6.21 0.51 down from 2000 | 77 | 0% | — | ||
7Seminars in ImmunologyElsevier BV · United States | 2.23Q1 | 5.11 1.07 down from 2000 | 156 | 4% | $4,370 | ||
8The Journal of ImmunologyAmerican Association of Immunologists · United States | 2.17Q1 | 7.15 0.42 up from 2000 | 5,241 | 49% | $3,500 | ||
9Journal of Allergy and Clinical ImmunologyElsevier BV · United States | 2.00Q1 | 5.51 1.08 up from 2000 | 1,306 | 42% | $4,900 | ||
10Journal of Leukocyte BiologyOxford University Press · United States | 1.53Q1 | 4.49 0.15 up from 2000 | 710 | 10% | $3,800 | ||
11International Reviews of ImmunologyTaylor & Francis · United States | 1.47Q1 | 2.18 2.42 down from 2000 | 100 | 0% | — | ||
12European Journal of ImmunologyWiley · Germany | 1.35Q1 | 3.93 0.09 down from 2000 | 1,728 | 55% | $4,550 | ||
13International ImmunologyOxford University Press · United Kingdom | 1.31Q1 | 3.54 0.39 up from 2000 | 608 | 38% | $3,530 | ||
14Journal of Clinical ImmunologySpringer Science+Business Media · United States | 1.29Q1 | 3.29 0.44 up from 2000 | 181 | 0% | $4,990 | ||
15Journal of AutoimmunityElsevier BV · United Kingdom | 1.25Q1 | 2.82 0.69 up from 2000 | 251 | 2% | $5,420 | ||
16Clinical & Experimental ImmunologyOxford University Press · United Kingdom | 1.17Q2 | 2.84 0.25 up from 2000 | 957 | 96% | $3,816 | ||
17Genes and ImmunitySpringer Nature · United States | 1.09Q2 | 2.91 0.16 up from 2000 | 57 | 4% | $3,190 | ||
18Clinical ImmunologyElsevier BV · Netherlands | 1.06Q2 | 2.72 0.55 up from 2000 | 295 | 2% | $4,400 | ||
19Current Opinion in ImmunologyElsevier BV · United Kingdom | 1.03Q2 | 11.53 2.42 up from 2000 | 381 | 1% | $4,410 | ||
20Springer Seminars in ImmunopathologySpringer Science+Business Media · Germany | 0.99Q2 | 1.62 0.56 down from 2000 | 126 | 10% | — | ||
21Immunologic ResearchSpringer Science+Business Media · United States | 0.99Q2 | 3.05 0.71 up from 2000 | 154 | 6% | $2,890 | ||
22ImmunologyWiley · United Kingdom | 0.94Q2 | 2.70 0.46 up from 2000 | 748 | 31% | $5,330 | ||
23Journal of Immunological MethodsElsevier BV · Netherlands | 0.92Q2 | 2.24 0.24 up from 2000 | 639 | 1% | $2,970 | ||
24Immunology and Cell BiologyWiley · Australia | 0.91Q2 | 2.43 0.24 up from 2000 | 252 | 10% | $3,750 | ||
25ImmunopharmacologyElsevier BV · Netherlands | 0.89Q2 | 2.09 0.70 up from 2000 | 330 | — | — | ||
26CytokineElsevier BV · United Kingdom | 0.89Q2 | 2.05 0.36 down from 2000 | 446 | 3% | $3,220 | ||
27Bulletin of the European Association of Fish PathologistsPublisher not listed | 0.83Q2 | 1.10no change | 59 | 0% | — | ||
28Journal of Interferon & Cytokine ResearchMary Ann Liebert, Inc. · United States | 0.81Q2 | 2.33 0.26 up from 2000 | 433 | 1% | — | ||
29Cellular ImmunologyElsevier BV · Netherlands | 0.79Q2 | 2.37 0.52 up from 2000 | 473 | 1% | $3,550 | ||
30Toxicologic PathologySAGE Publishing · United States | 0.78Q2 | 1.61 0.60 down from 2000 | 324 | 28% | $4,150 | ||
31Human ImmunologyElsevier BV · United States | 0.78Q3 | 2.19 0.34 up from 2000 | 439 | 3% | $3,600 | ||
32Journal of Reproductive ImmunologyElsevier BV · Netherlands | 0.73Q3 | 1.91 0.11 down from 2000 | 154 | 0% | $3,690 | ||
33Tissue AntigensWiley · United Kingdom | 0.73Q3 | 3.04 0.62 up from 2000 | 532 | 12% | — | ||
34ImmunogeneticsSpringer Science+Business Media · Germany | 0.72Q3 | 2.10 0.01 up from 2000 | 449 | 2% | $2,890 | ||
35Developmental & Comparative ImmunologyElsevier BV · United Kingdom | 0.72Q3 | 2.81 1.06 up from 2000 | 198 | 10% | $3,340 | ||
36Immunological ReviewsWiley · United States | 0.68Q3 | 7.08 0.59 up from 2000 | 356 | 6% | $5,000 | ||
37Scandinavian Journal of ImmunologyWiley · United Kingdom | 0.67Q3 | 1.63 0.22 down from 2000 | 527 | 55% | $4,480 | ||
38ImmunobiologyOAElsevier BV · Germany | 0.67Q3 | 1.06 0.63 down from 2000 | 230 | 2% | $2,840 | ||
39American Journal of Reproductive ImmunologyWiley · United Kingdom | 0.66Q3 | 1.76 0.01 down from 2000 | 280 | 6% | $4,460 | ||
40Immunology LettersElsevier BV · Netherlands | 0.64Q3 | 1.90 0.30 up from 2000 | 495 | 3% | $3,290 | ||
41International Journal of Clinical & Laboratory ResearchSpringer Science+Business Media · Germany | 0.64Q3 | 0.88 0.66 down from 2000 | 112 | — | — | ||
42Experimental and Clinical ImmunogeneticsKarger Publishers · Switzerland | 0.62Q3 | 2.64 0.51 up from 2000 | 85 | 6% | — | ||
43Cytokine & Growth Factor ReviewsElsevier BV · United Kingdom | 0.62Q3 | 7.71 1.52 up from 2000 | 74 | 3% | $4,900 | ||
44Inflammation ResearchSpringer Science+Business Media · Switzerland | 0.61Q3 | 1.29 0.26 down from 2000 | 432 | 3% | $4,790 | ||
45International Journal of ImmunopharmacologyElsevier BV · United Kingdom | 0.57Q3 | 1.25 0.05 up from 2000 | 245 | — | — | ||
46Veterinary Immunology and ImmunopathologyElsevier BV · Netherlands | 0.57Q4 | 1.37 0.08 down from 2000 | 477 | 7% | $3,250 | ||
47Clinical Reviews in Allergy & ImmunologySpringer Nature · United States | 0.53Q4 | 0.94 0.21 down from 2000 | 102 | 0% | $5,490 | ||
48Fish & Shellfish ImmunologyElsevier BV · United Kingdom | 0.49Q4 | 1.79 0.26 up from 2000 | 174 | 5% | $4,330 | ||
49Journal of Aquatic Animal HealthWiley · United States | 0.49Q4 | 1.29 0.32 up from 2000 | 143 | 0% | $3,500 | ||
50European Journal of ImmunogeneticsWiley · United Kingdom | 0.48Q4 | 1.61 0.31 up from 2000 | 144 | 2% | — |
Subfields of Immunology and Microbiology, with Immunology highlighted.
Journals
Citations made in 2001. Corpus-wide, 67.0% of core-journal articles and reviews published that year have at least one matched reference; the share varies by journal and field.
19 additional Immunology journals with metrics are unranked under this release’s eligibility rules: a journal needs at least 30 citable documents in 1998–2000, at least 80% of them with a subfield, and a positive world-average expectation. Ranks are within the whole category; filters hide rows without re-ranking. OJR excludes self-citations.
At a glance
Indicator year: 2001. Publication window: 1998–2000. How these summaries are calculated
- Ranked journals
- 59
- Window papers (baseline)
- 35,811 Change unavailable from indicator year 1998
- Median OJR
- 0.78 Change unavailable from indicator year 1998
- Rising journals (2025)
- 5
Window papers are the baseline paper population: citable papers (articles, reviews and conference papers) from 1998–2000 in all journals of the world-average baseline, including non-core journals, counted by each paper’s own subfield. They are not the papers of the ranked journals alone.
| Measure | Year series | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ranked journals | 56 | 59 | 63 | 65 | 62 | 64 | 68 | 72 | 71 | 74 | 76 | 79 | 81 | 86 | 83 | 88 | 90 | 96 | 94 | 90 | 92 | 87 | 88 | 88 | 88 | 86 | |
| Window papers (baseline) | 33,673 | 35,811 | 37,963 | 40,362 | 42,065 | 44,849 | 47,600 | 50,960 | 53,923 | 57,726 | 63,072 | 65,596 | 67,601 | 67,579 | 70,684 | 72,624 | 73,354 | 72,790 | 72,098 | 72,447 | 74,045 | 77,362 | 81,615 | 83,779 | 84,353 | 84,391 | |
| Median OJR | 0.72 | 0.78 | 0.834 | 0.82 | 0.830 | 0.88 | 0.89 | 0.959 | 1.002 | 1.15 | 1.100 | 1.09 | 1.096 | 1.04 | 1.08 | 1.06 | 1.05 | 0.95 | 0.921 | 0.970 | 0.931 | 0.932 | 0.967 | 0.956 | 0.922 | 0.87 |
How to read these rankings
- OJR, the OpenJournalRank Indicator
- A field-normalized 3-year citation impact, computed from OpenAlex with the NCI3 method. It divides the citations a journal’s papers received by the world average for papers of the same subfield, year and type, so 1.00 is the world average and 2.00 means twice as many citations as expected. Because it is normalized, it can be compared across fields. Read the methodology
- Quartiles
- Q1 to Q4 split the ranked journals of the list you are viewing into four equal groups by OJR. A journal’s quartile depends on the list: the same journal can be Q1 in its subfield and Q2 among all journals.
- Impact factor (2-year)
- Citations per paper over a two-year window, counted from OpenAlex. It is easy to compare with familiar impact factors but is not field-normalized, so compare it only within a field. It is not Clarivate’s Journal Impact Factor. Why it differs from the Journal Impact Factor
- Rank ranges
- Each rank in the latest year carries a likely range from 1,000 resamples of the journal’s papers. Where two journals’ ranges overlap, the data cannot tell them apart, so treat neighbouring ranks as ties.